JAMA Psychiatry

Regulatory barriers to conducting placebo-controlled studies of cann...abis leave clinicians and patients with little guidance. Exempting scientists from cannabis's Schedule I status is an expeditious solution to bridge the gap between evidence and practice. https://ja.ma/3npMyFF Meer weergeven